Interestingly, ARID1A mutations are found in cancers with an epigenetic disposition, which include EBV and MSI groups in gastric cancer and the CIMP-high subtype in colorectal cancer (73–83% and 39%, respectively) [15, 24]. Here, ARID1A is linked to gastric cancer.